Antidiabetic effects of add-on gynostemma pentaphyllum extract therapy with sulfonylureas in type 2 diabetic patients

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Huyen, V T T ^a,b,c   Phan, D V ^b   Thang, P ^c   Ky, P T ^d   Hoa, N K ^e   Ostenson, C G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c National Institute of Gerontology   (Viet Nam)

^d HANOI UNIVERSITY OF PHARMACY   (Viet Nam)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLICLAZIDE; GLUCOSE; GYNOSTEMMA PENTAPHYLLUM EXTRACT; HEMOGLOBIN A1C; INSULIN;

ADD ON THERAPY; ADULT; ANTHROPOMETRIC PARAMETERS; ANTIDIABETIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LIVER TOXICITY; MALE; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 84868706522     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/452313     Document Type: Article

References (22)

1. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
2. Winer N., Sowers J. R., Epidemiology of diabetes. Journal of Clinical Pharmacology 2004 44 4 397 405 2-s2.0-1642344350 10.1177/0091270004263017 (Pubitemid 38396785)
3. Holman R. R., Long-term efficacy of sulfonylureas: a United Kingdom prospective diabetes study perspective. Metabolism 2006 55 1 S2 S5 2-s2.0-33646941576 10.1016/j.metabol.2006.02.006
4. Turner R. C., Cull C. A., Frighi V., Holman R. R., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). Journal of the American Medical Association 1999 281 21 2005 2012 2-s2.0-0032983666 10.1001/jama.281.21.2005 (Pubitemid 29254858)
5. Norberg A., Nguyen K. H., Liepinsh E., Van Phan D., Nguyen D. T., Jörnvall H., Sillard R., Östenson C. G., A novel insulin-releasing substance, phanoside, from the plant Gynostemma pentaphyllum. Journal of Biological Chemistry 2004 279 40 41361 41367 2-s2.0-4744356796 10.1074/jbc.M403435200 (Pubitemid 39313575)
6. Hoa N. K., Norberg Å., Sillard R., Van Phan D., Thuan N. D., Dzung D. T. N., Jörnvall H., Östenson C. G., The possible mechanisms by which phanoside stimulates insulin secretion from rat islets. Journal of Endocrinology 2007 192 2 389 394 2-s2.0-33947356756 10.1677/joe.1.06948 (Pubitemid 46444440)
7. Megalli S., Davies N. M., Roufogalis B. D., Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat. Journal of Pharmacy and Pharmaceutical Sciences 2006 9 3 281 291 2-s2.0-33947523780 (Pubitemid 46614342)
8. Hung T. M., Hoang D. M., Kim J. C., Jang H. S., Ahn J. S., Min B. S., Protein tyrosine phosphatase 1B inhibitory by dammaranes from Vietnamese Giao-Co-Lam tea. Journal of Ethnopharmacology 2009 124 2 240 245 2-s2.0-67449119156 10.1016/j.jep.2009.04.027
9. Huyen V. T. T., Phan D. V., Thang P., Hoa N. K., Östenson C. G., Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Hormone and Metabolic Research 2010 42 5 353 357 2-s2.0-77952003251 10.1055/s-0030-1248298
10. Department of Material Medica, Hanoi College of Pharmacy, Textbook of Material Medica 2006 1
11. Department of Material Medica, Hanoi College of Pharmacy, Guideline of Material Medica Practice 2006 1
12. WHO, Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus 1999 Geneva, Switzerlands World Health Organization
13. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J., Coated charcoal immunoassay of insulin. Journal of Clinical Endocrinology and Metabolism 1965 25 10 1375 1384 2-s2.0-0013807029
14. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: Insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
15. Hanefeld M., Brunetti P., Schernthaner G. H., Matthews D. R., Charbonnel B. H., One-year glycemic control with a suifonyurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes. Diabetes Care 2004 27 1 141 147 2-s2.0-1042268736 10.2337/diacare.27.1.141 (Pubitemid 38196723)
16. Roghani M., Baluchnejadmojarad T., Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology 2010 17 1 55 59 2-s2.0-73649149403 10.1016/j.pathophys.2009.07.004
17. Nahas R., Moher M., Complementary and alternative medicine for the treatment of type 2 diabetes. Canadian Family Physician 2009 55 6 591 596 2-s2.0-67249114413
18. Tsuneki H., Ishizuka M., Terasawa M., Wu J. B., Sasaoka T., Kimura I., Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacology 2004 4 article no. 18 2-s2.0-12944291304 10.1186/1471-2210-4-18 (Pubitemid 40177096)
19. Davidson M. B., Peters A. L., An overview of metformin in the treatment of type 2 diabetes mellitus. American Journal of Medicine 1997 102 1 99 110 2-s2.0-0031053808 10.1016/S0002-9343(96)00353-1 (Pubitemid 27089992)
20. Charpentier G., Fleury F., Kabir M., Vaur L., Halimi S., Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients. Diabetic Medicine 2001 18 10 828 834 2-s2.0-0034791788 10.1046/j.1464-5491.2001.00582.x (Pubitemid 32953790)
21. Rodbard H. W., Blonde L., Braithwaite S. S., Brett E. M., Cobin R. H., Handelsman Y., Hellman R., Jellinger P. S., Jovanovic L. G., Levy P., Mechanick J. I., Zangeneh F., Parkin C. G., American association of clinical endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Practice 2007 13 supplement 1 1 68 2-s2.0-34547423755
22. Belsey J., Krishnarajah G., Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysis. Diabetes, Obesity and Metabolism 2008 10 1 1 7 2-s2.0-43449131548 10.1111/j.1463-1326.2008.00884.x